1. Home
  2. LMAT vs SLNO Comparison

LMAT vs SLNO Comparison

Compare LMAT & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$93.41

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Soleno Therapeutics Inc.

SLNO

Soleno Therapeutics Inc.

HOLD

Current Price

$53.01

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMAT
SLNO
Founded
1983
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.3B
IPO Year
2006
2014

Fundamental Metrics

Financial Performance
Metric
LMAT
SLNO
Price
$93.41
$53.01
Analyst Decision
Buy
Buy
Analyst Count
5
9
Target Price
$105.80
$83.00
AVG Volume (30 Days)
252.6K
1.4M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
0.93%
N/A
EPS Growth
30.57
108.90
EPS
0.68
0.59
Revenue
$249,602,000.00
$1,450,788.00
Revenue This Year
$14.21
$150.46
Revenue Next Year
$8.88
$50.37
P/E Ratio
$137.59
$89.83
Revenue Growth
13.53
138.82
52 Week Low
$79.01
$29.43
52 Week High
$118.01
$89.12

Technical Indicators

Market Signals
Indicator
LMAT
SLNO
Relative Strength Index (RSI) 35.69 77.32
Support Level $82.26 $48.91
Resistance Level $114.38 $55.47
Average True Range (ATR) 2.99 0.05
MACD -0.41 -0.52
Stochastic Oscillator 27.34 100.00

Price Performance

Historical Comparison
LMAT
SLNO

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: